Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
55,482,166
-
Total 13F shares
-
26,192,943
-
Share change
-
+358,079
-
Total reported value
-
$202,992,457
-
Put/Call ratio
-
160%
-
Price per share
-
$7.75
-
Number of holders
-
110
-
Value change
-
+$537,249
-
Number of buys
-
54
-
Number of sells
-
50
Institutional Holders of Voyager Therapeutics, Inc. - Common Stock, $0.001 par value (VYGR) as of Q3 2023
As of 30 Sep 2023,
Voyager Therapeutics, Inc. - Common Stock, $0.001 par value (VYGR) was held by
110 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
26,192,943 shares.
The largest 10 holders included
ARMISTICE CAPITAL, LLC, EcoR1 Capital, LLC, VANGUARD GROUP INC, BlackRock Inc., FARALLON CAPITAL MANAGEMENT LLC, PRICE T ROWE ASSOCIATES INC /MD/, Erste Asset Management GmbH, DIMENSIONAL FUND ADVISORS LP, GEODE CAPITAL MANAGEMENT, LLC, and ACADIAN ASSET MANAGEMENT LLC.
This page lists
111
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.